CompaniesNuSirt Biopharma

NuSirt Biopharma

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

4

As Collaborator

0

Total Enrollment

504

By Phase

PHASE2: 4

By Status

COMPLETED: 4
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
Today
NCT02151461
NCT02435277
NCT02546609
Hover over trial bars to see details

Recent Trials

NCT03364335Lead Sponsor
The Effect Of NS-0200 and NS-0300 Versus Placebo on Weight In Obesity
PHASE2Completed
267 participants
Started: Jan 8, 2018 · Completed: Aug 17, 2018
NCT02546609Lead Sponsor
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
PHASE2Completed
91 participants
Started: Nov 19, 2015 · Completed: Jan 31, 2017
NCT02435277Lead Sponsor
An Extension Protocol to Evaluate Dose Comparisons of Leucine-Metformin Combinations in Type 2 Diabetic Patients
PHASE2Completed
50 participants
Started: Oct 31, 2014 · Completed: Jan 31, 2016
NCT02151461Lead Sponsor
Dose Comparisons of Leucine-Metformin Combinations on Blood Glucose Levels In Type 2 Diabetic Patients
PHASE2Completed
96 participants
Started: Jul 31, 2014 · Completed: Jan 31, 2016